Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
2.
Dalton Trans ; 49(3): 638-650, 2020 Jan 21.
Artigo em Inglês | MEDLINE | ID: mdl-31819930

RESUMO

New neutral bis(alkyl) Sc and Y complexes [N,Npy,N-]Ln(CH2SiMe3)2(THF)n [n = 0, Ln = Sc (1Sc), Y (1Y); n = 1, Ln = Y (1YTHF)] stabilized by a tridentate monoanionic amidopyridinate ligand were straightforwardly prepared by alkane elimination, upon mixing ligand [N,Npy,N-]H and metal precursor Ln(CH2SiMe3)3(THF)2 in toluene at 0 °C. Depending on the work-up conditions, yttrium bis(alkyl)s were isolated as either a pentacoordinate Lewis base free complex [N,Npy,N-]Y(CH2SiMe3)2 (1Y) or as a hexacoordinate THF adduct [N,Npy,N-]Y(CH2SiMe3)2THF (1YTHF). For the smaller Sc ion the only solvent-free complex [N,Npy,N-]Y(CH2SiMe3)2 (1Sc) was isolated as a pentacoordinate species irrespective of the reaction/work-up/crystallization conditions applied. Complexes 1Ln (Ln = Y, Sc) and 1YTHF were scrutinized as pre-catalysts in ternary catalytic systems Ln/borate/AliBu3 (borate = [HNMe2Ph][B(C6F5)4] or [Ph3C][B(C6F5)4]), applied to isoprene (IP) polymerization, providing moderate activity albeit high selectivity with predominant formation of 1,4-cis polyisoprene (up to 99%). The same complexes proved to be effcient catalysts also for the intermolecular hydrolelementation of styrene with various EH sustrates (pyrrolidine, morpholine, Ph2PH, PhPH2, PhSH) affording linear anti-Markovnikov addition products exclusively. After a preliminary activation by B(C6F5)3, selected bis(alkyl) complexes from this series have been finally used as valuable pre-catalysts for the CO2 hydrosylilation to CH4 in the presence of organosilanes as reducing agents (PhMe2SiH, PhSiH3, Et2MeSiH).

3.
Dalton Trans ; 45(22): 9127-35, 2016 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-27163554

RESUMO

The interaction of the η(1)-tetrahydroborate copper(i) complex (triphos)Cu(η(1)-BH4) () with proton donors [CF3CH2OH (TFE), (CF3)2CHOH (HFIP), (CF3)3COH (PFTB), PhOH, p-NO2C6H4OH (PNP), p-NO2C6H4N[double bond, length as m-dash]NC6H4OH (PNAP), CF3OH] was a subject of a combined IR spectroscopic and theoretical investigation. Spectral (Δν) and thermodynamic (ΔH) parameters of dihydrogen bond (DHB) formation were determined experimentally. The terminal hydride ligand (characterized by the basicity factor Ej(BH) = 0.87 ± 0.01) is found to be a site of proton transfer which begins with nucleophilic substitution of BH4(-) by the alcohol oxygen atom on the copper center (BH pathway). The activation barrier computed for (CF3)2CHOH in CH2Cl2 - ΔG = 20.6 kcal mol(-1) - is in good agreement with the experimental value (ΔG = 20.0 kcal mol(-1)). An abnormal dependence of the reaction rate on the proton donor strength found experimentally in dichloromethane is explained computationally on the basis of the variation of the structural and energetic details of this process with the proton donor strength. In the second reaction mechanism found (CuH pathway), DHB complexes with the initial ROH coordination to the bridging hydride lead to B-Hbr bond cleavage with BH3 elimination. "Copper assistance" via the CuO interaction is not involved. This mechanism can be evoked to explain the occurrence of proton transfer in coordinating solvents.

4.
Environ Sci Process Impacts ; 17(1): 41-53, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25373743

RESUMO

Water quality characteristics and emerging organic pollutants were sampled along the San Pedro-Guayllabamba-Esmeraldas River and its main water pollution streams in the summer of 2013. The annual flow rate of the stream is 22 000 Mm(3) y(-1) and it collects the wastewater of Quito-Ecuador in the Andes and supplies drinking water to the city of Esmeraldas near the Pacific Ocean. The most persistent emerging pollutants were carbamazepine and acesulfame, which were found to be stable along the San Pedro-Guayllabamba-Esmeraldas River, whereas the concentration of most other organic emerging pollutants, such as caffeine, sulfamethoxazole, venlafaxine, O-desmethylvenlafaxine, and steroidal estrogens, was degraded to a large extent along the 300 km flow. The mass rate of the sum of cocaine and benzoylecgonine, its metabolite, was increased along the stream, which may be attributed to coca plantations and wild coca trees. This raises the possibility of using river monitoring as an indirect way to learn about changes in coca plantations in their watersheds. Several organic emerging pollutants, such as venlafaxine, carbamazepine, sulphamethoxazole, and benzoylecgonine, survived even the filtration treatment at the Esmeraldas drinking water system, though all except for benzoylecgonine are found below 20 ng L(-1), and are therefore not likely to cause adverse health effects. The research provides a way to compare drug consumption in a major Latin American city (Quito) and shows that the consumption of most sampled drugs (carbamazepine, venlafaxine, O-desmethylvenlafaxine, sulphamethoxazole, ethinylestradiol) was below their average consumption level in Europe, Israel, and North America.


Assuntos
Monitoramento Ambiental , Compostos Orgânicos/análise , Rios/química , Poluentes Químicos da Água/análise , Cidades , Equador
5.
Cell Death Differ ; 22(4): 643-53, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25301068

RESUMO

The death receptor Fas undergoes a variety of post-translational modifications including S-palmitoylation. This protein acylation has been reported essential for an optimal cell death signaling by allowing both a proper Fas localization in cholesterol and sphingolipid-enriched membrane nanodomains, as well as Fas high-molecular weight complexes. In human, S-palmitoylation is controlled by 23 members of the DHHC family through their palmitoyl acyltransferase activity. In order to better understand the role of this post-translational modification in the regulation of the Fas-mediated apoptosis pathway, we performed a screen that allowed the identification of DHHC7 as a Fas-palmitoylating enzyme. Indeed, modifying DHHC7 expression by specific silencing or overexpression, respectively, reduces or enhances Fas palmitoylation and DHHC7 co-immunoprecipitates with Fas. At a functional level, DHHC7-mediated palmitoylation of Fas allows a proper Fas expression level by preventing its degradation through the lysosomes. Indeed, the decrease of Fas expression obtained upon loss of Fas palmitoylation can be restored by inhibiting the lysosomal degradation pathway. We describe the modification of Fas by palmitoylation as a novel mechanism for the regulation of Fas expression through its ability to circumvent its degradation by lysosomal proteolysis.


Assuntos
Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Receptor fas/metabolismo , Acetiltransferases , Substituição de Aminoácidos , Apoptose , Linhagem Celular Tumoral , Cicloeximida/farmacologia , Células HEK293 , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/antagonistas & inibidores , Peptídeos e Proteínas de Sinalização Intracelular/genética , Lipoilação , Lisossomos/metabolismo , Processamento de Proteína Pós-Traducional , Estabilidade Proteica/efeitos dos fármacos , Inibidores da Síntese de Proteínas/farmacologia , Interferência de RNA , RNA Interferente Pequeno/metabolismo , Receptor fas/genética
6.
Cell Death Dis ; 1: e88, 2010 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-21368861

RESUMO

Fas ligand (FasL) is a transmembrane protein that regulates cell death in Fas-bearing cells. FasL-mediated cell death is essential for immune system homeostasis and the elimination of viral or transformed cells. Because of its potent cytotoxic activity, FasL expression at the cell surface is tightly regulated, for example, via processing by ADAM10 and SPPL2a generating soluble FasL and the intracellular fragments APL (ADAM10-processed FasL form) and SPA (SPPL2a-processed APL). In this study, we report that FasL processing by ADAM10 counteracts Fas-mediated cell death and is strictly regulated by membrane localization, interactions and modifications of FasL. According to our observations, FasL processing occurs preferentially within cholesterol and sphingolipid-rich nanodomains (rafts) where efficient Fas-FasL contact occurs, Fas receptor and FasL interaction is also required for efficient FasL processing, and FasL palmitoylation, which occurs within its transmembrane domain, is critical for efficient FasL-mediated killing and FasL processing.


Assuntos
Apoptose , Proteína Ligante Fas/metabolismo , Proteínas ADAM/metabolismo , Proteína ADAM10 , Secretases da Proteína Precursora do Amiloide/metabolismo , Ácido Aspártico Endopeptidases/metabolismo , Membrana Celular/metabolismo , Humanos , Lipoilação , Proteínas de Membrana/metabolismo , Ligação Proteica
7.
Cell Death Differ ; 14(4): 795-806, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17082815

RESUMO

The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38. Owing to the in utero lethality of daxx-deficient mice, the in vivo role of Daxx has been so far difficult to analyze. We have generated transgenic mice expressing a dominant-negative form of Daxx (Daxx-DN) in the T-cell lineage. We show that Daxx is recruited to the Fas receptor upon FasL engagement and that Daxx-DN expression protects activated T cells from Fas-induced cell death, by preventing the death-inducing signal complex to be properly formed. Normal lymphocyte development and homeostasis are nevertheless observed. Interestingly, we report that both in vitro and in vivo stimulation of Daxx-DN T-lymphocytes leads to increased proliferative T-cell responses. This increased proliferation is associated with a marked increase in tyrosine phosphorylation of LAT and ZAP70 as Daxx-DN favor their recruitment to the T-cell receptor (TCR) complex. These findings identify Daxx as a critical regulator of T-lymphocyte homeostasis by decreasing TCR-induced cell proliferation and by promoting Fas-mediated cell death.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Proteínas de Transporte/metabolismo , Proteína Ligante Fas/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Ativação Linfocitária , Proteínas Nucleares/metabolismo , Linfócitos T/citologia , Linfócitos T/imunologia , Receptor fas/fisiologia , Animais , Apoptose/fisiologia , Caspases/metabolismo , Proliferação de Células , Proteínas Correpressoras , Genes Dominantes , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Células Jurkat , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Camundongos Transgênicos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Chaperonas Moleculares , Linfócitos T/química
8.
Oncogene ; 25(26): 3735-44, 2006 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-16449964

RESUMO

Retinoic acid (RA), used as first-line therapy for acute promyelocytic leukemia (APL), exerts its antileukemic activity by inducing blast differentiation and activating tumor-selective TNF-related apoptosis-inducing ligand (TRAIL) signaling. To identify downstream mediators of RA signaling, we used retrovirus-mediated insertion mutagenesis in PLB985 leukemia cells and established the RA-resistant cell line WY-1. In PLB985, but not WY-1 cells, RA induced TRAIL and its DR4 and DR5 receptors. Knocking down TRAIL expression by RNA interference blocked RA-induced apoptosis. WY-1 cells are defective for RA-induced differentiation, G1 arrest and exhibit co-resistance to TRAIL. In WY-1 cells, a single virus copy is integrated into a novel RA-regulated gene termed RAM (retinoic acid modulator). RAM is expressed in the myelomonocytic lineage and extinguished by RA in PLB985, but not WY-1 cells. Whereas knocking down RAM expression by RNA interference promoted RA-induced differentiation and TRAIL-triggered apoptosis of PLB985 and WY-1 cells, overexpression of the predicted 109 amino-acid RAM open reading frame did not alter RA signaling in PLB985 cells. This indicates that, apart from encoding the putative RAM protein, RAM RNA may exert additional functions that are impaired by the retrovirus insertion. Our study demonstrates that RA induction of the TRAIL pathway is also operative in leukemia cells lacking an RARalpha oncofusion protein and identifies RAM as a novel RA-dependent modulator of myeloid differentiation and death.


Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Resistencia a Medicamentos Antineoplásicos/genética , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Glicoproteínas de Membrana/metabolismo , Tretinoína/farmacologia , Fator de Necrose Tumoral alfa/metabolismo , Proteínas rab de Ligação ao GTP/genética , Sequência de Aminoácidos , Apoptose/genética , Proteínas Reguladoras de Apoptose/genética , Proteínas Reguladoras de Apoptose/farmacologia , Sequência de Bases , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/genética , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intracelular/genética , Leucemia Mieloide/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/farmacologia , Dados de Sequência Molecular , Mutagênese Insercional , RNA Longo não Codificante , Receptores do Ácido Retinoico/efeitos dos fármacos , Receptores do Ácido Retinoico/genética , Receptores do Ácido Retinoico/metabolismo , Receptores do Ligante Indutor de Apoptose Relacionado a TNF , Receptores do Fator de Necrose Tumoral/efeitos dos fármacos , Receptores do Fator de Necrose Tumoral/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacologia , Receptor alfa de Ácido Retinoico , Receptores X de Retinoides/efeitos dos fármacos , Receptores X de Retinoides/metabolismo , Transdução de Sinais , Ligante Indutor de Apoptose Relacionado a TNF , Tretinoína/metabolismo , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/farmacologia , Proteínas rab de Ligação ao GTP/efeitos dos fármacos , Proteínas rab de Ligação ao GTP/metabolismo , Proteínas rab27 de Ligação ao GTP
9.
Science ; 308(5727): 1412, 2005 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-15933182
10.
Bioorg Med Chem ; 10(7): 2099-102, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11983505

RESUMO

The cell biological activity of novel retinoids and rexinoids is described. The stereochemistry of the new compounds was analyzed and ligand docking experiments revealed the structural basis of their RAR binding characteristics. The new ligands activate nuclear retinoic acid receptors (RAR, RXR) with distinct selectivity patterns, as determined in genetically engineered 'reporter' cells. The biological activity of the novel retinoids was assessed by differentiation of NB4 acute promyelocytic leukemia cells.


Assuntos
Receptores do Ácido Retinoico/efeitos dos fármacos , Fatores de Transcrição/efeitos dos fármacos , Tretinoína/farmacologia , Receptores X de Retinoides , Estereoisomerismo , Tretinoína/análogos & derivados , Tretinoína/química
11.
J Parasitol ; 88(6): 1268-70, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12537128

RESUMO

The helminth parasite fauna of a natural population of the octodontid, Ctenomys talarum, was studied. Parasites that were found included the nematodes Heligmostrongylus sp. and Trichuris sp. Total prevalence of parasitism was 92.3%, mean intensity of infection was 22.7 worms, and mean abundance was 21 worms. Prevalence and mean abundance of infection with Heligmostrongylus sp. were higher in C. talarum males relative to females. Ecological and physiological causes, as well as the mating system of the host species, influence the likelihood of sex differences in parasite infection. The low parasite burden and diversity of C. talarum are associated with restrictions imposed by the subterranean habitat and with life-history traits of these rodents. Whether these findings apply to other Ctenomys spp. is unknown.


Assuntos
Helmintíase Animal/epidemiologia , Doenças dos Roedores/epidemiologia , Fatores Etários , Animais , Argentina/epidemiologia , Meio Ambiente , Feminino , Helmintíase Animal/parasitologia , Masculino , Prevalência , Doenças dos Roedores/parasitologia , Roedores , Fatores Sexuais , Tricuríase/epidemiologia , Tricuríase/parasitologia , Tricuríase/veterinária
12.
Mol Endocrinol ; 15(7): 1154-69, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11435615

RESUMO

On their own, retinoid X receptor (RXR)-selective ligands (rexinoids) are silent in retinoic acid receptor (RAR)-RXR heterodimers, and no selective rexinoid program has been described as yet in cellular systems. We report here on the rexinoid signaling capacity that triggers apoptosis of immature promyelocytic NB4 cells as a default pathway in the absence of survival factors. Rexinoid-induced apoptosis displays all features of bona fide programmed cell death and is inhibited by RXR, but not RAR antagonists. Several types of survival signals block rexinoid-induced apoptosis. RARalpha agonists switch the cellular response toward differentiation and induce the expression of antiapoptosis factors. Activation of the protein kinase A pathway in the presence of rexinoid agonists induces maturation and blocks immature cell apoptosis. Addition of nonretinoid serum factors also blocks cell death but does not induce cell differentiation. Rexinoid-induced apoptosis is linked to neither the presence nor stability of the promyelocytic leukemia-RARalpha fusion protein and operates also in non-acute promyelocytic leukemia cells. Together our results support a model according to which rexinoids activate in certain leukemia cells a default death pathway onto which several other signaling paradigms converge. This pathway is entirely distinct from that triggered by RAR agonists, which control cell maturation and postmaturation apoptosis.


Assuntos
Apoptose/efeitos dos fármacos , Leucemia Promielocítica Aguda/patologia , Receptores do Ácido Retinoico/metabolismo , Retinoides/farmacologia , Transdução de Sinais , Fatores de Transcrição/metabolismo , Sangue , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Meios de Cultura , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Fragmentação do DNA , Dimerização , Resistência a Medicamentos , Marcação In Situ das Extremidades Cortadas , NF-kappa B/metabolismo , Receptores do Ácido Retinoico/antagonistas & inibidores , Receptores X de Retinoides , Retinoides/metabolismo , Fatores de Transcrição/antagonistas & inibidores , Células Tumorais Cultivadas
13.
Nat Med ; 7(6): 680-6, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11385504

RESUMO

The therapeutic and preventive activities of retinoids in cancer are due to their ability to modulate the growth, differentiation, and survival or apoptosis of cancer cells. Here we show that in NB4 acute promyelocytic leukemia cells, retinoids selective for retinoic-acid receptor-alpha induced an autoregulatory circuitry of survival programs followed by expression of the membrane-bound tumor-selective death ligand, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand, also called Apo-2L). In a paracrine mode of action, TRAIL killed NB4 as well as heterologous and retinoic-acid-resistant cells. In the leukemic blasts of freshly diagnosed acute promyelocytic leukemia patients, retinoic-acid-induced expression of TRAIL most likely caused blast apoptosis. Thus, induction of TRAIL-mediated death signaling appears to contribute to the therapeutic value of retinoids.


Assuntos
Apoptose , Leucemia Promielocítica Aguda/tratamento farmacológico , Glicoproteínas de Membrana/metabolismo , Tretinoína/uso terapêutico , Fator de Necrose Tumoral alfa/metabolismo , Antineoplásicos/uso terapêutico , Proteínas Reguladoras de Apoptose , Trióxido de Arsênio , Arsenicais/uso terapêutico , Caspases/metabolismo , Diferenciação Celular , Técnicas de Cocultura , Humanos , Immunoblotting , Proteínas Inibidoras de Apoptose , Leucemia Promielocítica Aguda/metabolismo , Leucemia Promielocítica Aguda/patologia , Glicoproteínas de Membrana/uso terapêutico , NF-kappa B/metabolismo , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Proteínas de Fusão Oncogênica/genética , Proteínas de Fusão Oncogênica/metabolismo , Óxidos/uso terapêutico , Comunicação Parácrina , Proteínas/genética , Proteínas/metabolismo , Receptores do Fator de Necrose Tumoral/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Fator 1 Associado a Receptor de TNF , Ligante Indutor de Apoptose Relacionado a TNF , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/uso terapêutico
15.
Science ; 213(4508): 604, 1981 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-17847454
16.
Science ; 202(4370): 820-1, 1978 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-17752438
17.
Science ; 201(4356): 582-9, 1978 Aug 18.
Artigo em Inglês | MEDLINE | ID: mdl-17794111

RESUMO

With 12 percent of U.S. electricity now being supplied by nuclear power, Commonwealth Edison has found nuclear plants to be good investments relative to other base load energy sources. The country's largest user of nuclear power, Commonwealth Edison, estimates that its commitment to nuclear saved its customers about 10 percent on their electric bills in 1977, compared to the cost with the next best alternative, coal. This advantage is seen as continuing, contrary to criticisms of the economics and reliability of nuclear power and claims that it has hidden subsidies. It is concluded that there is a need for both nuclear and coal and that government policy precluding or restricting either would be unwise.

19.
Science ; 166(3906): 688, 1969 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-17776748
20.
Science ; 166(3906): 686 passim, 1969 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-5823307
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...